The latest trading session saw Johnson & Johnson (JNJ) ending at $152.51, denoting a -0.44% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily loss of 0.04%.

Johnson & Johnson (NYSE:JNJ) responded with disappointment, claiming its actions were pro-competitive and aimed at ensuring patient safety. The company is weighing an appeal. The landmark verdict ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Multi-Factor Investor model based on the published strategy ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Multi-Factor Investor model based on the published strategy ...

I maintain my buy rating on JNJ, citing attractive valuation, improved technicals, and a raised intrinsic value target of $184 per share. JNJ's recent earnings beat expectations, with strong ...

On a special episode (first released on May 21, 2025) of The Excerpt podcast: For generations of Americans, the Johnson & Johnson brand has been a beloved one, as quintessentially American as ...

Hello everyone, I am Shagun Singh, Senior Research Analyst at RBC, and I'm very happy to host the next session with Johnson & Johnson. Joining us from the company is Joe Wolk, Chief Financial ...

“The association of the Johnson’s name with both the mother infant bond and mother’s touch as she uses the baby products is known as Johnson & Johnson’s Golden Egg,” a 2008 company prese ...